N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)butan-1-amine, 96%, 250mg

1-tert-Butylimidazole>98.0%(GC)(T)25g

(1R,3R)-5-Bromo-3-hydroxy-2,3-dihydrospiro[indene-1,5'-oxazolidine]-2',4'-dione, 97%, 250mg

(2R,3S)-1-tert-butyl 3-ethyl 2-(4-(cyclopentylamino)phenyl)piperidine-1,3-dicarboxylate, 97%, 1g

Silver foil 99.9% 0.25 x 100 x 100 mm 1 pc

8-METHYL-[1,2,4]TRIAZOLO[1,5-A]PYRIDINE, 95%, 250mg

(1R,2S)-2-Phenylcyclopropanamine hydrochloride, 95.0%, 1g

Ethyl 3-Indoleacetate>98.0%(GC)25g

N-Desmethylclozapine, >99%, 10mg

(S)-1-(3-Fluoro-4-(trifluoromethyl)phenyl)ethanamine, 95.0%, 100mg

Ethyl 3-hydroxy-2,2-dimethylpropanoate, 95.0%, 25g

Boc-4-methyl-D-phenylalanine, 95.0%, 10g

Refractive index standard, ROTI®Calipure, 1.49672 (20 °C), 15 ml, glass packaging